newsfilter
← Latest News
Business Wire·

AVROBIO to Share Comprehensive Gaucher Disease Program Update

Webcast on Wednesday, Dec. 7, 2022, at 8 am ET AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it will host a